(Q38192853)

30 August 2017

1 reference

title

Focal segmental glomerulosclerosis: towards a better understanding for the practicing nephrologist (English)

1 reference

focal segmental glomerulosclerosis

30 August 2017

1 reference

Sanjeev Sethi

1

1 reference

30 August 2017

Richard J Glassock

series ordinal

2

1 reference

30 August 2017

Fernando C Fervenza

series ordinal

3

1 reference

30 August 2017

language of work or name

English

0 references

publication date

2 March 2014

1 reference

Nephrology Dialysis Transplantation

30 August 2017

1 reference

30 August 2017

30

1 reference

30 August 2017

3

1 reference

30 August 2017

375-384

1 reference

Primary focal segmental glomerulosclerosis: pathology, histological variants, and pathogenesis

30 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Urinary CD80 excretion increases in idiopathic minimal-change disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Recurrent focal glomerulosclerosis: natural history and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Transmission of glomerular permeability factor from a mother to her child

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Modification of kidney barrier function by the urokinase receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

uPAR: a versatile signalling orchestrator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Regulation of cell signalling by uPAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Serum suPAR in patients with FSGS: trash or treasure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Chloride and the measurement of acid transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Hyperfibrinolysis, uPA/suPAR system, kynurenines, and the prevalence of cardiovascular disease in patients with chronic renal failure on conservative treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Circulating suPAR in two cohorts of primary FSGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Expression of podocyte-associated molecules in acquired human kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

The many masks of focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Collapsing glomerulopathy in HIV and non-HIV patients: a clinicopathological and follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

The spectrum of HIV-related nephropathy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Clinical trial of focal segmental glomerulosclerosis in children and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

A patient with nephrotic-range proteinuria and focal global glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

APOL1 and nephropathy progression in populations of African ancestry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Proteinuria should be used as a surrogate in CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

The MYH9/APOL1 region and chronic kidney disease in European-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

The new era of APOL1-associated glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

APOL1 localization in normal kidney and nondiabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

The spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA(Leu) gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Mycophenolate mofetil treatment for primary glomerular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: superiority of response to corticosteroid therapy over histopathologic patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Primary focal segmental glomerulosclerosis: clinical course and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Current and emerging treatments for idiopathic focal and segmental glomerulosclerosis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Rituximab-based novel strategies for the treatment of immune-mediated glomerular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Posttransplant recurrence of primary glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Abatacept in B7-1-positive proteinuric kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Three-dimensional analysis of glomerular morphology in patients with subtotal nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Genetics, clinical and pathological features of glomerulonephrites associated with mutations of nonmuscle myosin IIA (Fechtner syndrome)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Sirolimus Therapy of Focal Segmental Glomerulosclerosis Is Associated With Nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

Induction of B7-1 in podocytes is associated with nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU035

21 January 2018

Identifiers

DOI

10.1093/NDT/GFU035

1 reference

30 August 2017

1 reference